These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19903070)

  • 21. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
    Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
    Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
    Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
    Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
    Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. M-CSF, c-Fms, and signaling in osteoclasts and their precursors.
    Ross FP
    Ann N Y Acad Sci; 2006 Apr; 1068():110-6. PubMed ID: 16831911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of the HIF-2α in epithelial ovarian cancer and clinical significance].
    Wang Q; Peng K; He L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 39(9):889-93. PubMed ID: 25269497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CSF-1 and its receptor CSF-1R in non-hematopoietic neoplasms.
    Kascinski B
    Cancer Treat Res; 2002; 107():285-92. PubMed ID: 11775455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis.
    Ide H; Hatake K; Terado Y; Tsukino H; Okegawa T; Nutahara K; Higashihara E; Horie S
    Hum Cell; 2008 Feb; 21(1):1-6. PubMed ID: 18190394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Cα in epithelial ovarian cancer.
    Qi H; Sun B; Zhao X; Du J; Gu Q; Liu Y; Cheng R; Dong X
    Oncol Rep; 2014 Aug; 32(2):771-9. PubMed ID: 24898696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the cell cycle inhibitor p27KIP1 is a new prognostic marker associated with survival in epithelial ovarian tumors.
    Newcomb EW; Sosnow M; Demopoulos RI; Zeleniuch-Jacquotte A; Sorich J; Speyer JL
    Am J Pathol; 1999 Jan; 154(1):119-25. PubMed ID: 9916926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Authors' reply: Prognostic significance of mean platelet volume in epithelial ovarian cancer.
    Ma XG; Wang YM; Xue FX
    J Obstet Gynaecol Res; 2014 Jun; 40(6):1832. PubMed ID: 24888961
    [No Abstract]   [Full Text] [Related]  

  • 31. Gonadotropin signalling in epithelial ovarian cancer.
    Mertens-Walker I; Baxter RC; Marsh DJ
    Cancer Lett; 2012 Nov; 324(2):152-9. PubMed ID: 22634496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kindlin-2 inhibits serous epithelial ovarian cancer peritoneal dissemination and predicts patient outcomes.
    Ren C; Du J; Xi C; Yu Y; Hu A; Zhan J; Guo H; Fang W; Liu C; Zhang H
    Biochem Biophys Res Commun; 2014 Mar; 446(1):187-94. PubMed ID: 24583125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular diagnosis in type I epithelial ovarian cancer.
    Sadłecki P; Walentowicz-Sadłecka M; Grabiec M
    Ginekol Pol; 2017; 88(12):692-697. PubMed ID: 29303228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.
    Sun W; Gui L; Zuo X; Zhang L; Zhou D; Duan X; Ren W; Xu G
    J Transl Med; 2016 Mar; 14():75. PubMed ID: 26983758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme.
    Yokoyama Y; Morishita S; Takahashi Y; Hashimoto M; Tamaya T
    Br J Cancer; 1997; 76(8):977-82. PubMed ID: 9376277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA.
    Hu Y; Li D; Wu A; Qiu X; Di W; Huang L; Qiu L
    Cancer Lett; 2017 May; 393():60-67. PubMed ID: 28216373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature.
    Posadas EM; Davidson B; Kohn EC
    Curr Opin Oncol; 2004 Sep; 16(5):478-84. PubMed ID: 15314519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways.
    Uemura Y; Kobayashi M; Nakata H; Kubota T; Bandobashi K; Saito T; Taguchi H
    Int J Mol Med; 2006 Aug; 18(2):365-73. PubMed ID: 16820947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer.
    Pranjol MZ; Gutowski N; Hannemann M; Whatmore J
    Biomolecules; 2015 Nov; 5(4):3260-79. PubMed ID: 26610586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of plasminogen activator inhibitor-2 in epithelial ovarian cancer: a favorable prognostic factor related to the actions of CSF-1.
    Chambers SK; Ivins CM; Carcangiu ML
    Int J Cancer; 1997 Dec; 74(6):571-5. PubMed ID: 9421350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.